AEA-D8
AEA-D8 Basic information
- Product Name:
- AEA-D8
- Synonyms:
-
- ARACHIDONOYL ETHANOLAMIDE-D8
- ANANDAMIDE-D8
- AEA-D8
- N-(2-HYDROXYETHYL)-5Z,8Z,11Z,14Z-EICOSATETRAENAMIDE-5,6,8,9,11,12,14,15-D8
- (5Z,8Z,11Z,14Z)-5,6,8,9,11,12,14,15-octadeuterio-N-(2-hydroxyethyl)icosa-5,8,11,14-tetraenamide
- CAS:
- 924894-98-4
- MF:
- C22H37NO2
- MW:
- 347.54
- Mol File:
- Mol File
AEA-D8 Chemical Properties
- solubility
- 1 mg/ml EtOH:PBS pH 7.2: can dilute 1:1.6 (>380 μg/ml); 10 mg/ml EtOH:PBS pH 7.2: can dilute 1:1 (>5 mg/ml) (fro; 100 ?g/ml EtOH:PBS pH 7.2: can dilute 1:1.6 (>38 μg/ml) (; DMF: >10 mg/ml (from AEA); DMSO: >30 mg/ml (from AEA); Ethanol: >100 mg/ml (from AEA); PBS pH 7.2: <100 μg/ml (from AEA)
- form
- Liquid
- color
- Colorless to light yellow
AEA-D8 Usage And Synthesis
Description
Arachidonoyl ethanolamide-
Uses
Anandamide-d8 is a deuterated labeled Anandamide[1]. Anandamide is an endocannabinoid. Anandamide modulates both neuronal and immune functions through two protein-coupled cannabinoid receptors (CB1 and CB2). Anandamide can activate numerous other receptors like PPARS, TRPV1, and GPR18/GPR55. Anandamide also has potential anti-fungal and anti-inflammatory activities. Anandamide can be used for the research of Alzheimer’s disease (AD) and ulcerative colitis[2][3][4][5][6].
Definition
ChEBI: Anandamide is an N-acylethanolamine 20:4 resulting from the formal condensation of carboxy group of arachidonic acid with the amino group of ethanolamine. It has a role as a neurotransmitter, a vasodilator agent and a human blood serum metabolite. It is an endocannabinoid and a N-acylethanolamine 20:4. It is functionally related to an arachidonic acid.
in vivo
Anandamide (10 mg/kg, IP, once) considerably lowers the increase of glycemia in response to glucose ingestion compared with control, and this is associated with an improvement of glucose tolerance[3].
Anandamide (100 ng, ICV bilateral injection, single) partially prevents streptozotocin (STZ)-induced cognitive impairments, changes in synaptic markers and ventricle enlargement[4].
Anandamide exerts anti-inflammatory activities, attenuating the development of inflammation in a mouse model of ulcerative colitis[5].
Anandamide alleviates lipopolysaccharide (LPS)-induced neuroinflammation in rat primary microglial cultures[2].
References
1. Devane, W.A., Hanus, L., Breuer, A., et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258(5090),1946-1949(1992).
2. Felder, C.C., Briley, E.M., Axelrod, J., et al. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-
AEA-D8Supplier
- Tel
- 18818260767
- sales@chemegen.com
- Tel
- 027-59626688 18771149750
- sales@amyjet.com
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
- Tel
- 800-364-9897
- sales@caymanchem.com
- Tel
- 18566777408